2 options
FDA Risk Evaluation and Mitigation Strategies (REMS) : description and effect on generic drug development / Agata Dabrowska.
- Format:
- Government document
- Website/Database
- Author/Creator:
- Bodie, Agata, author.
- Series:
- CRS report ; R44810.
- Report / Congressional Research Service ; R44810
- Language:
- English
- Subjects (All):
- United States. Food and Drug Administration.
- United States.
- Generic drugs.
- Pharmaceutical industry--United States.
- Pharmaceutical industry.
- Pharmaceutical industry--Materials management--United States.
- Drugs, Generic.
- Medical Subjects:
- Drugs, Generic.
- Genre:
- Bibliographies.
- Online resources.
- bibliographies.
- Physical Description:
- 1 online resource.
- Updated irregularly
- Edition:
- [Library of Congress public edition].
- Other Title:
- Food and Drug Administration Risk Evaluation and Mitigation Strategies (REMS)
- Place of Publication:
- [Washington, D.C.] : Congressional Research Service, 2018-
- Notes:
- The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141.
- Report includes bibliographical references.
- Description based on contents viewed on Jan. 4, 2019; title from CRS report home page.
- OCLC:
- 1080952561
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.